Suppr超能文献

髓样分化因子88衔接蛋白样分子(Mal)/TIRAP的TIR结构域变体导致髓样分化因子88(MyD88)结合丧失及Toll样受体2(TLR2)/Toll样受体4(TLR4)信号传导减弱。

A TIR domain variant of MyD88 adapter-like (Mal)/TIRAP results in loss of MyD88 binding and reduced TLR2/TLR4 signaling.

作者信息

Nagpal Kamalpreet, Plantinga Theo S, Wong Joyce, Monks Brian G, Gay Nicholas J, Netea Mihai G, Fitzgerald Katherine A, Golenbock Douglas T

机构信息

Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA.

出版信息

J Biol Chem. 2009 Sep 18;284(38):25742-8. doi: 10.1074/jbc.M109.014886. Epub 2009 Jun 9.

Abstract

The adapter protein MyD88 adapter-like (Mal), encoded by TIR-domain containing adapter protein (Tirap) (MIM 606252), is the most polymorphic of the five adapter proteins involved in Toll-like receptor signaling, harboring eight non-synonymous single nucleotide polymorphisms in its coding region. We screened reported mutations of Mal for activity in reporter assays to test the hypothesis that variants of Mal existed with altered signaling potential. A TIR domain variant, Mal D96N (rs8177400), was found to be inactive. In reconstituted cell lines, Mal D96N acted as a hypomorphic mutation, with impaired cytokine production and NF-kappaB activation upon lipopolysaccharide or PAM2CSK4 stimulation. Moreover, co-immunoprecipitation studies revealed that Mal D96N is unable to interact with MyD88, a prerequisite for downstream signaling to occur. Computer modeling data suggested that residue 96 resides in the MyD88 binding site, further supporting these findings. Genotyping of Mal D96N in three different cohorts suggested that it is a rare mutation. We, thus, describe a rare variant in Mal that exerts its effect via its inability to bind MyD88.

摘要

衔接蛋白髓样分化因子88衔接蛋白样分子(Mal)由含TIR结构域的衔接蛋白(Tirap)(MIM 606252)编码,是Toll样受体信号通路中涉及的五种衔接蛋白中多态性最高的,其编码区存在八个非同义单核苷酸多态性。我们在报告基因检测中筛选了已报道的Mal突变的活性,以检验存在具有改变的信号传导潜能的Mal变体这一假设。发现一种TIR结构域变体Mal D96N(rs8177400)无活性。在重组细胞系中,Mal D96N表现为一种亚效突变,在脂多糖或PAM2CSK4刺激下细胞因子产生和NF-κB激活受损。此外,免疫共沉淀研究表明,Mal D96N无法与MyD88相互作用,而这是下游信号传导发生的前提条件。计算机建模数据表明,96位残基位于MyD88结合位点,进一步支持了这些发现。在三个不同队列中对Mal D96N进行基因分型表明它是一种罕见突变。因此,我们描述了Mal中的一种罕见变体,它通过无法结合MyD88发挥作用。

相似文献

1
A TIR domain variant of MyD88 adapter-like (Mal)/TIRAP results in loss of MyD88 binding and reduced TLR2/TLR4 signaling.
J Biol Chem. 2009 Sep 18;284(38):25742-8. doi: 10.1074/jbc.M109.014886. Epub 2009 Jun 9.
2
MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses.
J Biol Chem. 2009 Sep 4;284(36):24192-203. doi: 10.1074/jbc.M109.023044. Epub 2009 Jul 10.
4
Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling.
Mol Immunol. 2012 Oct;52(3-4):108-16. doi: 10.1016/j.molimm.2012.05.003. Epub 2012 Jun 4.
6
TRAM is involved in IL-18 signaling and functions as a sorting adaptor for MyD88.
PLoS One. 2012;7(6):e38423. doi: 10.1371/journal.pone.0038423. Epub 2012 Jun 7.
7
Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling.
Proc Natl Acad Sci U S A. 2009 Jun 23;106(25):10260-5. doi: 10.1073/pnas.0812956106. Epub 2009 Jun 8.
8
MyD88 adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction.
J Biol Chem. 2006 Apr 14;281(15):10489-95. doi: 10.1074/jbc.M508892200. Epub 2006 Jan 26.
10
NF-kappaB activation by the Toll-IL-1 receptor domain protein MyD88 adapter-like is regulated by caspase-1.
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3372-7. doi: 10.1073/pnas.0608100104. Epub 2007 Feb 20.

引用本文的文献

1
TIRAP, TRAM, and Toll-Like Receptors: The Untold Story.
Mediators Inflamm. 2023 Mar 7;2023:2899271. doi: 10.1155/2023/2899271. eCollection 2023.
3
Traditional Chinese Medicine and Natural Products: Potential Approaches for Inflammatory Bowel Disease.
Front Pharmacol. 2022 Jul 7;13:892790. doi: 10.3389/fphar.2022.892790. eCollection 2022.
5
Exome sequencing in patient-parent trios suggests new candidate genes for early-onset primary sclerosing cholangitis.
Liver Int. 2021 May;41(5):1044-1057. doi: 10.1111/liv.14831. Epub 2021 Mar 11.
6
The Roles of Inflammasomes in Host Defense against .
Pathogens. 2021 Jan 25;10(2):120. doi: 10.3390/pathogens10020120.
7
The Mechanism of Aureusidin in Suppressing Inflammatory Response in Acute Liver Injury by Regulating MD2.
Front Pharmacol. 2020 Oct 28;11:570776. doi: 10.3389/fphar.2020.570776. eCollection 2020.

本文引用的文献

2
Genetic association and expression studies indicate a role of toll-like receptor 8 in pulmonary tuberculosis.
PLoS Genet. 2008 Oct;4(10):e1000218. doi: 10.1371/journal.pgen.1000218. Epub 2008 Oct 10.
3
Pyogenic bacterial infections in humans with MyD88 deficiency.
Science. 2008 Aug 1;321(5889):691-6. doi: 10.1126/science.1158298.
4
Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis.
Am J Respir Crit Care Med. 2008 Oct 1;178(7):710-20. doi: 10.1164/rccm.200803-462OC. Epub 2008 Jul 17.
6
The NALP3 inflammasome is involved in the innate immune response to amyloid-beta.
Nat Immunol. 2008 Aug;9(8):857-65. doi: 10.1038/ni.1636. Epub 2008 Jul 11.
7
Targeting toll-like receptor signaling pathways for design of novel immune therapeutics.
Curr Drug Discov Technol. 2008 Mar;5(1):29-38. doi: 10.2174/157016308783769441.
9
Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response.
J Biol Chem. 2008 May 23;283(21):14295-308. doi: 10.1074/jbc.M800501200. Epub 2008 Mar 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验